Erie Indemnity (ERIE) Stake Increased by Brown Advisory Inc.

Share on StockTwits

Brown Advisory Inc. grew its stake in Erie Indemnity (NASDAQ:ERIE) by 0.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 75,382 shares of the financial services provider’s stock after acquiring an additional 242 shares during the quarter. Brown Advisory Inc. owned 0.16% of Erie Indemnity worth $10,050,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the company. Vanguard Group Inc increased its stake in shares of Erie Indemnity by 1.7% in the 3rd quarter. Vanguard Group Inc now owns 2,390,401 shares of the financial services provider’s stock valued at $304,847,000 after acquiring an additional 40,987 shares during the last quarter. Vanguard Group Inc. increased its stake in shares of Erie Indemnity by 1.7% in the 3rd quarter. Vanguard Group Inc. now owns 2,390,401 shares of the financial services provider’s stock valued at $304,847,000 after acquiring an additional 40,987 shares during the last quarter. BlackRock Inc. increased its stake in shares of Erie Indemnity by 4.9% in the 4th quarter. BlackRock Inc. now owns 1,002,319 shares of the financial services provider’s stock valued at $133,620,000 after acquiring an additional 47,171 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Erie Indemnity by 4.9% in the 4th quarter. Dimensional Fund Advisors LP now owns 280,178 shares of the financial services provider’s stock valued at $37,349,000 after acquiring an additional 12,976 shares during the last quarter. Finally, Bank of New York Mellon Corp increased its stake in shares of Erie Indemnity by 7.7% in the 3rd quarter. Bank of New York Mellon Corp now owns 207,583 shares of the financial services provider’s stock valued at $26,474,000 after acquiring an additional 14,816 shares during the last quarter. 31.77% of the stock is owned by institutional investors.

Shares of ERIE opened at $175.95 on Friday. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.06 and a quick ratio of 2.06. Erie Indemnity has a 52-week low of $110.22 and a 52-week high of $188.02. The company has a market capitalization of $8.09 billion, a P/E ratio of 31.93 and a beta of 0.50.

Erie Indemnity (NASDAQ:ERIE) last issued its quarterly earnings data on Thursday, February 21st. The financial services provider reported $1.19 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.01 by $0.18. Erie Indemnity had a return on equity of 31.89% and a net margin of 12.10%. The business had revenue of $576.47 million during the quarter. Equities analysts forecast that Erie Indemnity will post 6.08 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 23rd. Investors of record on Monday, April 8th will be given a $0.90 dividend. The ex-dividend date of this dividend is Friday, April 5th. This represents a $3.60 annualized dividend and a dividend yield of 2.05%. Erie Indemnity’s dividend payout ratio is presently 65.34%.

In other Erie Indemnity news, SVP Louis F. Colaizzo acquired 750 shares of the firm’s stock in a transaction that occurred on Monday, December 31st. The stock was acquired at an average cost of $133.00 per share, for a total transaction of $99,750.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Salvatore Correnti acquired 320 shares of the firm’s stock in a transaction that occurred on Wednesday, December 26th. The stock was acquired at an average price of $126.81 per share, with a total value of $40,579.20. Following the completion of the transaction, the director now directly owns 320 shares in the company, valued at approximately $40,579.20. The disclosure for this purchase can be found here. Insiders purchased a total of 1,820 shares of company stock valued at $240,079 over the last quarter. 46.84% of the stock is owned by insiders.

A number of analysts have recently commented on the company. BidaskClub cut Erie Indemnity from a “strong-buy” rating to a “buy” rating in a research note on Wednesday. ValuEngine upgraded Erie Indemnity from a “hold” rating to a “buy” rating in a research report on Monday, February 4th.

WARNING: “Erie Indemnity (ERIE) Stake Increased by Brown Advisory Inc.” was first reported by Ticker Report and is owned by of Ticker Report. If you are accessing this article on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The original version of this article can be viewed at https://www.tickerreport.com/banking-finance/4222706/erie-indemnity-erie-stake-increased-by-brown-advisory-inc.html.

Erie Indemnity Profile

Erie Indemnity Company operates as a managing attorney-in-fact for the subscribers at the Erie Insurance Exchange in the United States. The company provides sales, underwriting, and policy issuance services for the policyholders on behalf of the Erie Insurance Exchange. Its sales related services include agent compensation, and sales and advertising support services; and underwriting services comprise underwriting and policy processing, as well as provides administrative support, information technology, and customer services.

Further Reading: Stock Selection – What is cash flow?

Institutional Ownership by Quarter for Erie Indemnity (NASDAQ:ERIE)

Receive News & Ratings for Erie Indemnity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Erie Indemnity and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Bank of Montreal Can Has $1.67 Million Position in Evolent Health Inc
Bank of Montreal Can Has $1.67 Million Position in Evolent Health Inc
BlackRock Income Trust  Position Lowered by Bank of America Corp DE
BlackRock Income Trust Position Lowered by Bank of America Corp DE
Ballew Advisors Inc Lowers Holdings in iShares Edge MSCI Min Vol USA ETF
Ballew Advisors Inc Lowers Holdings in iShares Edge MSCI Min Vol USA ETF
Bank of America Corp DE Has $527,000 Holdings in La Jolla Pharmaceutical
Bank of America Corp DE Has $527,000 Holdings in La Jolla Pharmaceutical
Ventas  Upgraded by ValuEngine to Buy
Ventas Upgraded by ValuEngine to Buy
Aspiriant LLC Has $600,000 Stake in iShares Core S&P Mid-Cap ETF
Aspiriant LLC Has $600,000 Stake in iShares Core S&P Mid-Cap ETF


© 2006-2019 Ticker Report